Olmesartan medoxomil/hydrochlorothiazide

DRUG2 trials

Sponsors

Daiichi Sankyo

Conditions

Hypertension

Phase 4

An Examination of the Safety and Blood Pressure Lowering Effect of Increasing Doses of Benicar® and Benicar® HCT in Patients With Hypertension

CompletedNCT00185068

Daiichi SankyoHypertension

Start: 2004-03-31End: 2004-10-31Target: 110Updated: 2005-09-16

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

CompletedNCT00412932

Daiichi SankyoHypertension

Start: 2006-12-31End: 2008-04-30Updated: 2009-09-22

Related Papers

Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertension.

2012-10-014 citations

Blood pressure-lowering efficacy of an olmesartan medoxomil/hydrochlorothiazide-based treatment algorithm in elderly patients (age ≥65 years) stratified by age, sex and race: subgroup analysis of a 12-week, open-label, single-arm, dose-titration study.

2011-06-014 citations